project of biostatistics
TRANSCRIPT
![Page 1: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/1.jpg)
![Page 2: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/2.jpg)
Project
![Page 3: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/3.jpg)
Faculty of Engineering
Biomedical Engineering Department
Prevalence and risk factors of chronic kidney disease:
a population study in the Tibetan populationBy: * Mohammad Mahdi Sekhavat Pisheh – 932011113017 ([email protected]) S. Mohammad Zargar – 932011113013 Mohammad Hosein AliNaghi – 932011113022
Biostatistics
Spring 2016
Supervisor: Dr. Marateb
![Page 4: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/4.jpg)
4
First page of article
![Page 5: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/5.jpg)
5
ISI
![Page 6: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/6.jpg)
6
IF, SJR, Quartile
![Page 7: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/7.jpg)
7
#Citations
![Page 8: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/8.jpg)
Research Question
8
Is the prevalence of Chronic Kidney Disease (CKD) in the Tibetan population who have mentioned risk factors below, More than the prevalence of CKD in the population who don’t have them?
Risk factors: Hypertension, albuminuria, hyperuricemia, high hematocrit.
![Page 9: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/9.jpg)
PICOT criteria
Population: 1289 person of the Tibetan adult(>=18 years) population in Lhasa city and Dangxiong county of Lhasa city.
Intervention: ---Comparison Group: Adults(>=18 years) who have not intended
risk factor (every time we survey).Outcome: Risk of CKDTime: --- (cross-sectional study)
9
![Page 10: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/10.jpg)
FINER criteria
Feasible
10
![Page 11: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/11.jpg)
FINER criteria
InterestingNovel
11
![Page 12: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/12.jpg)
FINER criteria
EthicalRelevant
12
![Page 13: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/13.jpg)
Research Hypothesis
: The prevalence of CKD in adults(>=18 years) who have intended risk factor (every time we survey).
: The prevalence of CKD in adults(>=18 years) who have NOT intended risk factor (every time we survey).
13
Two-Sided Hypothesis:
NULL HypothesisAlternative Hypothesis
![Page 14: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/14.jpg)
Research Objective
We conducted a population-based survey in Tibet to identify the prevalence and associated risk factors of CKD in subjects living at altitudes of >3500 m.
14
![Page 15: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/15.jpg)
Variables in the Research
15
No Variable Type Measurement Scale Categories
1 Age (years) Independent Interval -
2 Weight (kg) Independent Interval -
3 Serum creatinine (μmol/L) Independent Interval -
4 Blood cholesterol (mmol/L) Independent Interval -
5 Serum triglyceride (mmol/L) Independent Interval -
6 Blood uric acid (μmol/L) Independent Interval -
7 Fast blood glucose (mmol/L) Independent Interval -
8 Systolic blood pressure (mmHg) Independent Interval -
9 Diastolic blood pressure (mmHg) Independent Interval -
10 Hemoglobin (g/L) Independent Interval -
11 Hematocrit Independent Interval -
![Page 16: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/16.jpg)
Variables in the Research
16
No Variable Type Measurement Scale Categories
12 BMI Independent Interval -
13 ≥High school education Independent Nominal Above/Under
14 Health insurance coverage Independent Nominal Yes/No
15 Smoking Independent Nominal Yes/No
16 History of CKD Independent Nominal Yes/No
17 Family history of diabetes Background Nominal Yes/No
18 Family history of hypertension Background Nominal Yes/No
19 Family history of CKD Background Nominal Yes/No
20 Repeatedly respiratory tract infection Background Nominal Yes/No
21 Nephrotoxic medications Independent Nominal Yes/No
22 Obesity Independent Nominal Yes/No
![Page 17: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/17.jpg)
Variables in the Research
17
No Variable Type Measurement Scale Categories
23 Central obesity Independent Nominal Yes/No
24 Metabolic syndrome Independent Nominal Yes/No
25 Hypertension Independent Nominal Yes/No
26 Diabetes Independent Nominal Yes/No
27 Hyperlipidemia Independent Nominal Yes/No
28 Hyperuricemia Independent Nominal Yes/No
29 Cardiovascular disease Independent Nominal Yes/No
30 eGFR <60 mL/min/1.73 m2 Independent Nominal Yes(<60)/No(>60)
31 ACR >30 mg/g Independent Nominal Yes(>30)/No(<30)
32 Hematuria Independent Nominal Yes/No
33 CKD Status Dependent Nominal Yes/No
![Page 18: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/18.jpg)
18
![Page 19: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/19.jpg)
19
![Page 20: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/20.jpg)
Result
20
The overall prevalence of CKD (stages 1–5) was 19.1% (95% CI: 17.9–22.3%) after adjustment for age and gender (Table 2). The prevalence of CKD in CKD stage from 1 to 5 was 12.8%, 4.6%, 1.1%, 0.3% and 0.3%, respectively. The prevalence of CKD was higher in the subjects with hyperuricaemia (32.3% versus 12.5%, P = 0.0001), hypertension (29.2% versus 11.9%, P = 0.0001), hyperlipidaemia (23.1% versus 10.1%, P < 0.001) and metabolic syndrome (21.8% versus 12.1%, P < 0.001) compared with subjects without these indicators, respectively. No difference of CKD prevalence was found between male and female subjects (18.9% versus 19.9%, P = 0.45), but the prevalence of CKD increased with increasing age in both groups (P < 0.001 across age groups).
![Page 21: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/21.jpg)
Implementation of Article
21
![Page 22: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/22.jpg)
Dataset
22
![Page 23: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/23.jpg)
Normality of variables
23
One-Sample Kolmogorov-Smirnov Test
![Page 24: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/24.jpg)
What tests?
24
Chi-Square test >> Between CKD and Hypertension
Mann-Whitney test >> Between CKD and Age
Bi-Variate correlation test >> Between eGFR and Age
![Page 25: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/25.jpg)
Chi square test
25
BetweenCKD and Hypertension
![Page 26: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/26.jpg)
Chi-Square test
26
![Page 27: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/27.jpg)
Mann-Whitney test
27
BetweenCKD and age
![Page 28: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/28.jpg)
Bi-Variate correlation test
28
BetweeneGFR and age
![Page 29: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/29.jpg)
Bi-Variate correlation test
29
Scatter plot
![Page 30: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/30.jpg)
Sample size (N)calculation
30
![Page 31: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/31.jpg)
Sample size calculation
31
![Page 32: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/32.jpg)
Sample size calculation
32
![Page 33: Project of Biostatistics](https://reader036.vdocuments.net/reader036/viewer/2022062904/5874bda31a28ab8f508b4573/html5/thumbnails/33.jpg)
Thanks for your attention